Search
    Skip to main content
    Advertisement

    Johnson & Johnson

    1. Business
    2. Companies
    3. Johnson & Johnson
    J&J adds rare disease wAIHA to Imaavy's potential uses pharmaphorum09:05
    J&J secures extended Nice approval for Darzalex following earlier refusal Pharmaceutical Technology04:48
    J&J lights up $1bn offer for pan-KRAS developer Firefly pharmaphorum09:49
    Will late-stage immunology and oncology wins redefine Johnson & Johnson's (JNJ) post-biosimilar narrative? Simply Wall St05:27
    Johnson & Johnson beats lawsuit alleging that talc caused three women's cancer The Economic Times21:17
    Johnson & Johnson scores defense verdict in 2nd talc bellwether in Los Angeles superior court Law.com20:17
    Johnson & Johnson (JNJ) is attracting investor attention: Here is what you should know Zacks10:00

    Latest News

    In the last 8 hours
    New Talvey® (talquetamab-tgvs) plus Darzalex Faspro® (daratumumab and hyaluronidase-fihj) data… PR Newswire (Press Release)06:38
    Yesterday
    J&J Trial Over Doctor's Cancer Death Ends In Settlement Law36020:29 12-Jun-26
    Johnson & Johnson (JNJ) Rises Higher Than Market: Key Facts Zacks18:51 12-Jun-26
    J&J poster puts Spravato remission data at center of treatment-resistant-depression growth push Drug Discovery & Development17:55 12-Jun-26
    J&J Moves to Shed Cases Claiming Talc Products Caused Cancer Bloomberg Law16:35 12-Jun-26
    Johnson & Johnson Just Paid $1 Billion for a Technology That Could Crack One of Cancer's Most "Undruggable" Targets.… The Motley Fool14:35 12-Jun-26
    J&J reports data from Phase II/III ENERGY trial for wAIHA Clinical Trials Arena11:04 12-Jun-26
    In the last 7 days
    J&J Expands U.S. Availability Of Tecnis PureSee Iol For Cataract Patients RTT News09:36 11-Jun-26
    J&J adds rare disease wAIHA to Imaavy's potential uses pharmaphorum09:05 11-Jun-26
    Johnson & Johnson Expands U.S. Availability of Tecnis PureSee Iol, an Advanced Lens Option for… Business Wire (Press Release)07:45 11-Jun-26
    England: Group litigation order approved in Johnson & Johnson baby powder case Scottish Legal News06:00 11-Jun-26
    Johnson & Johnson's Imaavy Shows Rapid And Durable Hemoglobin Improvements In Pivotal Waiha Study RTT News05:22 11-Jun-26
    Johnson & Johnson will acquire Firefly Bio, betting $1 billion on cancer treatment The State, South Carolina16:20 10-Jun-26
    Noteworthy Wednesday Option Activity: LLY, JNJ, CASY Nasdaq14:39 10-Jun-26
    Johnson & Johnson Hit with $32 Million Verdict in Los Angeles Asbestos Trial Business Wire (Press Release)11:23 10-Jun-26
    Bayer's asundexian starts EU review for ischaemic stroke pharmaphorum08:07 10-Jun-26
    Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma PharmaTimes10:02 9-Jun-26
    J&J to acquire Firefly Bio for $1bn to enhance oncology pipeline Pharmaceutical Business Review06:23 9-Jun-26
    J&J secures extended NICE approval for Darzalex following earlier refusal Pharmaceutical Technology04:48 9-Jun-26
    Johnson & Johnson Update: Wave 4 Correction May Be Nearing Completion After Wave 3 Extension Barchart03:58 9-Jun-26
    Johnson & Johnson Paying $1B For Oncology Startup Firefly Law36016:31 8-Jun-26
    J&J lights up $1bn offer for pan-KRAS developer Firefly pharmaphorum09:49 8-Jun-26
    STAT Plus: J&J spends $1 billion to enter KRAS race for cancer treatments STAT09:27 8-Jun-26
    J&J to buy cancer drug technology developer Firefly Bio for $1 billion Rock Hill Herald08:39 8-Jun-26
    Johnson & Johnson to buy Firefly Bio for $1 billion Rock Hill Herald08:29 8-Jun-26
    Johnson & Johnson to Acquire Firefly Bio, Inc. to Expand Oncology Pipeline with Novel Degrader… Business Wire (Press Release)08:08 8-Jun-26
    Johnson & Johnson beats talc lawsuit in California court case cosmeticsbusiness.com07:23 8-Jun-26
    Will Late-Stage Immunology and Oncology Wins Redefine Johnson & Johnson's (JNJ) Post-Biosimilar Narrative? Simply Wall St05:27 8-Jun-26
    Why Johnson & Johnson May Be the Closest Thing Investors Can Find to a Bulletproof Dividend Stock The Motley Fool10:33 6-Jun-26
    In the last month
    Johnson & Johnson beats lawsuit alleging that talc caused three women's cancer The Economic Times21:17 5-Jun-26
    Johnson & Johnson Scores Defense Verdict in 2nd Talc Bellwether in Los Angeles Superior Court Law.com20:17 5-Jun-26
    BREAKING: J&J Cleared Of Talc Liability In LA Bellwether Trial Law36019:30 5-Jun-26
    J&J beats lawsuit alleging that talc caused three women's cancer The News Tribune, Washington18:34 5-Jun-26
    No 'Conspiracy To Hide Asbestos' In Talc, J&J Atty Tells Jury Law36022:07 4-Jun-26
    Talc Lawyers Ask Los Angeles Jury to Hit Johnson & Johnson With Punitive Damages: 'The Language They Speak is Money' Law.com20:32 4-Jun-26
    Johnson & Johnson (JNJ) Exceeds Market Returns: Some Facts to Consider Zacks18:47 4-Jun-26
    Johnson And Johnson Autoimmune Trial Data And What It Means For JNJ Simply Wall St09:19 4-Jun-26
    EULAR 26 hears of treatment advances in lupus pharmaphorum07:46 4-Jun-26
    CereVasc, Inc. Announces Over-Subscribed $85 Million Series C Financing to Advance its Novel… PR Newswire (Press Release)06:40 4-Jun-26
    Johnson & Johnson reports phase 2 data showing nipocalimab reduced SLE disease activity PharmaTimes06:18 4-Jun-26
    J&J’s nipocalimab meets primary endpoint in Phase II JASMINE study Hospital Management05:17 4-Jun-26
    J&J Innovative Medicine Korea wins reimbursement for Darzalex SC regimen in newly diagnosed AL amyloidosis Korea Biomedical Review01:09 4-Jun-26
    'This Is Their Document': Jury Told J&J Docs Prove Talc Lies Law36021:30 3-Jun-26
    Paul Hastings Settles With J&J Unit in Bankruptcy Fee Dispute Bloomberg Law14:38 3-Jun-26
    Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know Zacks10:00 3-Jun-26
    The Expanding Frontier of Chemical Engineering: ChemE Show 2026 Opens June 9-10 in Houston PR Newswire (Press Release)08:50 3-Jun-26
    A Look At Johnson & Johnson (JNJ) Valuation After Recent Share Price Weakness Simply Wall St01:17 3-Jun-26
    Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus… PR Newswire (Press Release)00:08 3-Jun-26
    Johnson & Johnson presents new data further reinforcing the role of nipocalimab in lowering the … PR Newswire (Press Release)00:08 3-Jun-26
    Talc Tester Says J&J Never Pressured Him To Hide Asbestos Law36021:36 2-Jun-26
    Johnson & Johnson Hopes to Dethrone AbbVie's Biggest Growth Driver. Here's Why Investors Shouldn't Panic The Motley Fool14:58 2-Jun-26
    J&J’s Erleada prostate cancer study shows significant reduction in risk of metastasis PMLiVE07:59 2-Jun-26
    Ga. Panel Says New Trial Warranted In J&J Talc Cancer Suit Law36020:47 1-Jun-26
    ASCO26: key readouts in lung cancer Clinical Trials Arena11:16 1-Jun-26
    J&J Drug Reduces Prostate Cancer Progression NewsMax08:41 1-Jun-26
    ASCO26: BMS and J&J debut shining multiple myeloma data Clinical Trials Arena07:11 1-Jun-26
    Rybrevant Faspro™ (amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable… PR Newswire (Press Release)08:37 31-May-26
    Johnson & Johnson's Phase 3 prostate cancer study shows Erleada® (apalutamide) before and after … PR Newswire (Press Release)08:33 31-May-26
    J&J prostate cancer drug reduces risk of cancer spread and death in late-stage study The Tribune, California08:29 31-May-26
    Johnson & ​Johnson prostate cancer drug reduces risk of cancer spread and death in late-stage… The Times of India08:10 31-May-26
    ASCO 26: Big win for Erleada in perioperative prostate cance... pharmaphorum08:03 31-May-26
    Johnson & Johnson (JNJ) Stock Slides as Market Rises: Facts to Know Before You Trade Zacks18:52 29-May-26
    Johnson & Johnson Wins Talc Verdict in Oklahoma, Appeal in Pennsylvania Law.com17:17 29-May-26
    J&J’s Abiomed Defeats Getinge Unit at Heart-Pump Patent Trial Bloomberg Law15:37 29-May-26
    Rybrevant® (amivantamab-vmjw) plus Lazcluze® (lazertinib) demonstrates prolonged clinical… PR Newswire (Press Release)14:02 29-May-26
    Weekly Buzz: AZN, JNJ Get FDA Nod; Lly To Acquire Curevo; Apge Advances Zumilokibart RTT News10:50 29-May-26
    National Coordination of Class Actions - Lessons from Strathdee v. Johnson & Johnson JD Supra10:07 29-May-26
    New Tecvayli® (teclistamab-cqyv) data demonstrate superior progression-free and overall… PR Newswire (Press Release)08:20 29-May-26
    FDA Approves Expansion Of Johnson & Johnson's Tremfya In Treating Psoriatic Arthritis Joint Damage RTT News04:55 29-May-26
    Johnson & Johnson: FDA Approves Label Expansion For Tremfya RTT News01:51 29-May-26
    J&J Unit Cleared In Blood Pump Patent Suit In Mass. Law36019:42 28-May-26
    FDA approves label expansion, cementing Tremfya® as the only Il‑23 inhibitor proven to help… PR Newswire (Press Release)19:16 28-May-26
    J&J Gets Trial Win In Oklahoma Talc Mesothelioma Case Law36015:18 28-May-26
    Is Johnson & Johnson (JNJ) a Buy as Wall Street Analysts Look Optimistic? Zacks10:34 28-May-26
    John Slump Launches Metis MedTech Following Atraverse Medical Acquisition by Johnson & Johnson PR Newswire (Press Release)09:39 28-May-26
    J&J Stock Gains Nearly 12% Year to Date: Buy, Sell or Hold Now? Zacks09:33 28-May-26
    Is Johnson & Johnson Stock Outperforming the Dow? Barchart06:44 28-May-26
    Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results Business Wire (Press Release)16:25 27-May-26
    Johnson & Johnson to Acquire Atraverse Medical JD Supra13:28 27-May-26
    Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Novo Nordisk and Bayer Zacks04:20 27-May-26
    President Trump's Drug Pricing Policies Could Hurt Drugmakers' Profits. Time to Sell Pharma Stocks? The Motley Fool15:46 26-May-26
    Why Johnson & Johnson Might Be the Smartest Dividend King to Buy in Today's Market The Motley Fool17:22 25-May-26
    J&J 's 'Pure' Baby Powder Ads Were Pure Lies, Jury Told Law36022:00 22-May-26
    Notable Friday Option Activity: JNJ, QUBT, QRVO Nasdaq16:05 22-May-26
    Cash Dividend On The Way From Johnson & Johnson (JNJ) Nasdaq11:00 22-May-26
    Abu Dhabi unveils smart surgical network with J&J Gulf News09:53 22-May-26
    Abu Dhabi Health launches the world’s first smart surgical network powered by artificial intelligence Voice Of Emirates05:30 22-May-26
    Johnson And Johnson MedTech Moves And Innovation Hub Tie In Shape Outlook Simply Wall St04:26 22-May-26
    J&J Used Ellipsis To Nix Asbestos In Report to FDA, Jury Told Law36021:44 21-May-26
    9th Circ. Told To Reject J&J Unit's $442M Antitrust Appeal Law36020:33 21-May-26
    Johnson & Johnson (JNJ) Outperforms Broader Market: What You Need to Know Zacks18:45 21-May-26
    The Zacks Analyst Blog Highlights Johnson & Johnson, Oracle, Netflix and Espey Zacks12:28 21-May-26
    Johnson & Johnson Advances Creation of Global Intelligent OR Network in collaboration with… Business Wire (Press Release)07:03 21-May-26
    Prof. Hired By J&J In 1970s Found Asbestos In Talc, Jury Told Law36023:51 20-May-26
    Top Stock Reports for Johnson & Johnson, Oracle & Netflix Zacks18:05 20-May-26
    Toxicologist Denies J&J Wanted To 'Control' Talc Study Law36022:15 19-May-26
    J&J's Pipeline Progress & New Drugs Promise Stronger Long-Term Growth Zacks12:23 19-May-26
    3 Dividend Kings to Buy and Hold for 20 Years The Motley Fool11:42 19-May-26
    Johnson & Johnson Joins The HELIX Tech/Science Innovation Campus Coming To New Brunswick Patch10:42 19-May-26
    Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It Zacks10:10 19-May-26
    Meet the Dividend King With a Higher Credit Rating Than the U.S. Government The Motley Fool07:59 19-May-26
    Comic Gets Serious About Mom's Cancer At J&J Talc Trial Law36021:58 18-May-26
    Supreme Court Rejects Drugmakers’ Challenge to Medicare Price Negotiation Program Barchart20:46 18-May-26
    Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now Zacks12:53 18-May-26
    Rutgers Business School propels graduating student into Johnson & Johnson leadership program PR Newswire (Press Release)09:04 18-May-26
    Johnson & Johnson Launches 'Gut Tunnel' Experience in Singapore Antara News06:33 18-May-26
    Johnson & Johnson Launches ‘Gut Tunnel’ Experience in Singapore to Highlight the Importance of Endoscopic Remission in… The Hindu Business Line05:43 18-May-26
    Soros Fund Management discloses stakes in Berkshire Hathaway, Mastercard, and Johnson & Johnson Cryptopolitan21:28 15-May-26
    Johnson & Johnson’s Caplyta demonstrates phase III promise for depression European Pharmaceutical Review16:11 15-May-26
    One Blue-Chip Stock Is Up 11% While the S&P 500 Struggles Benzinga12:30 15-May-26
    How Investors Are Reacting To Johnson & Johnson (JNJ) Expanding Its Coronary Lithotripsy Device Portfolio Simply Wall St18:05 14-May-26
    Johnson & Johnson bladder cancer survey reveals toll of surgery, BCG treatment FiercePharma16:10 14-May-26
    Groundbreaking global survey captures the significant patient burden experienced with current… PR Newswire (Press Release)16:05 14-May-26
    Why Is Johnson & Johnson (JNJ) Down 3.5% Since Last Earnings Report? Zacks12:33 14-May-26
    Yuhan gets $30 mil. from J&J as Lazcluze-Rybrevant reaches Europe Korea Biomedical Review01:52 14-May-26
    view more headlines
    13 Jun 06:38

    About our Johnson & Johnson news

    Latest news on Johnson & Johnson, the American multinational pharmaceutical, known for developing healthcare, pharmaceuticals, and consumer products. Stay updated on stories about their pioneering medical advancements, including vaccines, treatments, and medical devices. Explore insights into the company’s financial performance, share prices, leadership changes, and global strategies.

    Business Top Stories

    Nvidia CEO Jensen Huang calls AI ‘Insanely profitable’ for TSMC. How to play tsm stock here. Barchart09:07Nvidia Top Tech Brands AI
    Nvidia CEO Jensen Huang says this will be the next $1 trillion company The Motley Fool07:22Nvidia Top Tech Brands AI
    A price war is brewing between OpenAI and Anthropic — And it could make AI a lot cheaper for your business Entrepreneur Magazine09:17OpenAI Anthropic AI
    The SpaceX IPO just created one of the biggest wealth events in Silicon Valley history. Here… Business Insider14:03OpenAI Anthropic AI
    Is your spousal Social Security benefit bigger than your retirement benefit? Here's how to tell. The Motley Fool09:21
    Master the art of spending in retirement Kiplinger.com08:20
    eVTOL Stock Face-Off: Is Joby Aviation or Archer Aviation the Better Buy Right Now? The Motley Fool17:18Joby Aviation FAA Aerospace and Defense
    How Buying Archer Aviation Stock Today Could 10X Your Net Worth The Motley Fool06:11Joby Aviation FAA Aerospace and Defense
    Why is Rocket Lab stock trading higher on Friday? Benzinga07:28Rocket Lab Nasdaq Global Stock Markets
    Space stocks got crushed on SpaceX's big day. Is the sell-off a warning or a buying opportunity? The Motley Fool13:17Rocket Lab Nasdaq Global Stock Markets
    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.